More Business Wire
View Older Stories View Newer Stories-
KB Home Announces the Grand Opening of Its Newest Community in Popular Hollister, California
-
Imperial declares first quarter 2025 dividend
-
Imperial announces fourth quarter 2024 financial and operating results
-
Peakstone Realty Trust Announces Tax Treatment of 2024 Distributions
-
Janus Henderson Group plc Reports Fourth Quarter and Full-Year 2024 Results
-
First BanCorp Announces Strategic Reorganization
-
E2open Ocean Shipping Index Shows Geopolitical Tensions, Labor Shortages and Port Congestion Driving Significant Increases in Global Transit Times
-
The Cannabist Company to Report Fourth Quarter and Full Year 2024 Results on March 13, 2025
-
Newegg Sells Out of NVIDIA RTX 50 Series GPUs in Record Time
-
WisdomTree Announces Fourth Quarter 2024 Results
-
Virtus Investment Partners Announces Financial Results for Fourth Quarter 2024
-
Bunge Limited Finance Corp. Announces Extension of Exchange Offers
-
Vestis Reports First Quarter 2025 Results; Reaffirms FY25 Guidance; Announces Chief Financial Officer and Chief Legal Officer Transitions
-
Phillips 66 Reports Fourth-Quarter Results and Announces Next Phase of Strategic Initiatives
-
Faraday Future to Empower Strategic Growth through Key Proposals at Next Extraordinary General Meeting
-
SES AI Provides Preliminary Fourth Quarter 2024 Revenue and Liquidity Results
-
Gold Reserve Announces Decision to Deregister Class A Common Shares
-
Bristol Myers Squibb Receives Positive CHMP Opinion for Opdivo® (nivolumab) plus Yervoy® (ipilimumab) as a First-Line Treatment Option for Adult Patients with Unresectable or Advanced Hepatocellular
-
Colgate Announces 4th Quarter and Full Year 2024 Results
-
Church & Dwight Reports Fourth Quarter and Full Year 2024 Results
-
Bristol Myers Squibb Receives Positive CHMP Opinion for CAR T Cell Therapy Breyanzi for Relapsed or Refractory Follicular Lymphoma
-
Blackstone Secured Lending Announces Fourth Quarter and Full Year 2024 Earnings Release and Conference Call
-
Merck Receives Positive EU CHMP Opinion for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Pneumococcal Vaccination in Adults
-
Booz Allen Hamilton Announces Third Quarter Fiscal Year 2025 Results
-
REPLY: Coding and Cybersecurity, Registration Is Now Open for the Reply Hack The Code Challenge 2025
-
Golden Snake Dances in Rome: China and Italy Join for a Vibrant Spring Festival Celebration
-
ExxonMobil Announces 2024 Results
-
Eaton Reports Record Fourth Quarter 2024 Results, with Strong Orders and Backlog Growth, and Issues Guidance on 2025 Outlook
-
Civeo Announces Quarterly Dividend
-
Algonquin Power & Utilities Corp. Announces Leadership Transition
-
Ares Capital Corporation Announces Tax Reporting Information for Calendar Year 2024
-
Chevron Reports Fourth Quarter 2024 Results
-
ArcBest Announces Fourth Quarter and Full Year 2024 Results
-
Revvity Announces Financial Results for the Fourth Quarter and Full Year of 2024
-
Dorian LPG Ltd. Announces Third Quarter Fiscal Year 2025 Financial Results
-
CuriosityStream Announces Quarterly Dividend Increase
-
Abridge Hires Experienced Tech Executive Sagar Sanghvi as CFO to Fuel Next Phase of Growth
-
Ares Commercial Real Estate Corporation Announces Tax Reporting Information for Calendar Year 2024
-
C the Signs Announces Investment From Khosla Ventures to Advance AI-Powered Early Cancer Detection
-
Tikehau Capital: Disclosure of Shares Repurchases from 24 January 2025 to 30 January 2025
-
eDreams ODIGEO Sets New Growth Guidance Across Subscribers, Profitability, and Cash Generation
-
Kirin Holdings: Improving The Sustainability Of Black Tea Farms In Sri Lanka Through The Regenerative Tea Scorecard In Conjunction With The Rainforest Alliance
-
GE HealthCare Invests $138 Million in Cork, Ireland Manufacturing Facility to Address Increasing Contrast Media Demand
-
Meiji Seika Pharma Receives Approval for Adding Domestic Manufacturing Sites in Japan for KOSTAIVE®, a Self-amplifying mRNA Vaccine Against COVID-19
-
Rosenblatt Regains Independence
-
Median Technologies Reports 2024 Key Financial Indicators and 2025 Outlook
-
Vertex Announces CASGEVY® Reimbursement Agreement for the Treatment of Sickle Cell Disease in England
-
Imedi Media Holding: Statement Concerning Media Freedom and Plurality in Georgia
-
Poxel’s partner Sumitomo Pharma reports TWYMEEG® gross sales in Japan for Q4 2024 and FY 2024 sales forecast
-
Kirin Holdings: Conducting Human Rights Due Diligence For Sustainable Sourcing Of Sri Lankan Tea Leaves
